Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells

Cancer Res. 1994 Oct 15;54(20):5280-3.

Abstract

MDA-MB-468 human breast cancer cells lack estrogen receptors, overexpress epidermal growth factor (EGF) receptors, and are growth inhibited by EGF. We show that treatment of MDA-MB-468 cells with EGF leads to inhibition of cell proliferation, fragmentation of DNA into nucleosomal oligomers, and the development of apoptotic morphology. This treatment is associated with increased expression of c-myc, c-fos, jun family members, and transforming growth factor beta 1 mRNA and with partial proteolytic cleavage of poly(ADP-ribose) polymerase and lamin B. The observation that EGF can mediate apoptosis in EGF receptor-overexpressing cells has important implications for clinical efforts directed at the EGF receptor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Apoptosis / physiology*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Breast Neoplasms / physiopathology*
  • Cell Division / drug effects
  • Cell Survival / drug effects
  • DNA, Neoplasm / drug effects*
  • Epidermal Growth Factor / pharmacology*
  • Genes, Immediate-Early / drug effects
  • Humans
  • Poly(ADP-ribose) Polymerases / metabolism
  • Proto-Oncogene Proteins c-myc / metabolism
  • Tumor Cells, Cultured

Substances

  • DNA, Neoplasm
  • Proto-Oncogene Proteins c-myc
  • Epidermal Growth Factor
  • Poly(ADP-ribose) Polymerases